About HKTDC | Media Room | Contact HKTDC | Wish List Wish List () | My HKTDC |
Save As PDF Print this page

Import Restrictions Imposed on Opioid Analgesic Drug

The Drug Enforcement Administration has issued a final order that temporarily schedules the opioid MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine), including its salts, isomers and salts of isomers, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. MT-45 is an opioid analgesic drug with pharmacological effects similar to morphine.

As a result, this substance will be subject to the regulatory controls and administrative, civil and criminal sanctions applicable to schedule I controlled substances on persons who manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess, MT-45. This order is effective 12 January and will be in effect for two years, with a possible extension of one year, pending completion of the permanent scheduling process.

Content provided by Picture: HKTDC Research
Comments (0)
Shows local time in Hong Kong (GMT+8 hours)

HKTDC welcomes your views. Please stay on topic and be respectful of other readers.
Review our Comment Policy

*Add a comment (up to 5,000 characters)